Market News (Page 93) - TendieTensor

Market News Page 93 of 161 • 4,002 articles

Abacus Global Management Enhances Shareholder Returns with Annual Dividend and $10 Million Share Repurchase Program

Benzinga • Globe Newswire

Abacus Global Management Enhances Shareholder Returns with Annual Dividend and $10 Million Share Repurchase Program

11/06/2025 04:06 PM • Abacus Global Management announced an annual cash dividend of $0.20 per share and a $10 million share repurchase program, demonstrating confidence in its long-term business model and strong financial performance.

ABL - The company reported its strongest quarter to date, has record cash levels, increasing capital inflows, growing fee income, and is implementing a shareholder-friendly capital allocation strategy with dividend and buyback program

#dividend #share repurchase #alternative asset management #financial services

Lam Research Corporation Declares Quarterly Dividend

Benzinga • Prnewswire

Lam Research Corporation Declares Quarterly Dividend

11/06/2025 04:05 PM • Lam Research Corporation announced a quarterly dividend of $0.26 per share, payable on January 7, 2026, to shareholders of record on December 3, 2025. The dividend is subject to future Board of Directors' review and approval.

GOOGL - Trading at 28x earnings, lower than Nasdaq-100's 39x; launched successful AI products like AI Overviews and Gemini app; secured a significant partnership with Anthropic worth tens of billions; generated $73 billion in free cash flow; projected to remain at the forefront of AI technology growth
LRCX - Company is maintaining consistent dividend payments, indicating financial stability and commitment to shareholder value. The forward-looking statement suggests ongoing financial health and strategic planning.

#dividend #semiconductor #quarterly payment #wafer fabrication

Denali Therapeutics Announces Board and Executive Leadership Updates

GlobeNewswire Inc. • Denali Therapeutics Inc.

Denali Therapeutics Announces Board and Executive Leadership Updates

11/06/2025 04:00 PM • Denali Therapeutics appointed Tim Van Hauwermeiren to its Board of Directors and announced the departure of Chief Medical Officer Carole Ho to Eli Lilly, with Peter Chin assuming the Acting Chief Medical Officer role.

JAZZ - Mentioned as having an exclusive partnership with Zymeworks for zanidatamab development
DNLI - Routine leadership transition with internal promotion and strategic board addition

#leadership changes #board appointment #medical officer transition #biotech

Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires

GlobeNewswire Inc. • Inventiva

Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires

11/06/2025 04:00 PM • Inventiva announced details for its Mixed General Assembly on November 27, 2025, including approving the new CEO Andrew Obenshain's compensation terms and the departure conditions for former CEO Frédéric Cren.

ONC - Mentioned as having an exclusive partnership with Zymeworks for zanidatamab development
IVA - The article describes a routine corporate governance event with a leadership transition, showing no significant positive or negative market implications

#General Assembly #CEO transition #compensation #biopharmaceutical #MASH treatment

ORIC® Pharmaceuticals Announces Publication in Cancer Research on the Discovery and Development of Enozertinib, a Highly Selective, Brain-Penetrant EGFR Inhibitor

GlobeNewswire Inc. • Oric Pharmaceuticals

ORIC® Pharmaceuticals Announces Publication in Cancer Research on the Discovery and Development of Enozertinib, a Highly Selective, Brain-Penetrant EGFR Inhibitor

11/06/2025 04:00 PM • ORIC Pharmaceuticals published research in Cancer Research detailing enozertinib, a highly selective brain-penetrant EGFR inhibitor targeting non-small cell lung cancer mutations, demonstrating potential for treating intracranial disease.

ORIC - Company published promising preclinical data showing a novel drug's potential to address unmet medical needs in cancer treatment, with a patient case demonstrating complete response in systemic and brain metastases

#enozertinib #EGFR #lung cancer #brain metastases #cancer research

GlobeNewswire Inc. • Globe Newswire

IREN Reports Q1 FY26 Results

11/06/2025 04:00 PM • IREN Limited reported record Q1 FY26 financial results, securing a $9.7bn multi-year GPU cloud services contract with Microsoft and targeting $3.4bn AI Cloud annualized run-rate revenue by end of 2026.

BAYRY - Potential milestone payment of €180 million related to Nubeqa sales and strong product growth forecasts
IREN - Reported record revenue growth of 355%, secured major Microsoft contract, expanded GPU infrastructure, and demonstrated strong financial performance with significant net income increase

#AI Cloud #GPU #Microsoft #Cloud Services #Data Centers

Combined General Meeting of November 27, 2025 - Availability of the preparatory documents

GlobeNewswire Inc. • Inventiva

Combined General Meeting of November 27, 2025 - Availability of the preparatory documents

11/06/2025 04:00 PM • Inventiva has announced the availability of preparatory documents for its Combined General Meeting on November 27, 2025, which will address the appointment of a new CEO, Andrew Obenshain, and discuss compensation terms for the outgoing CEO, Frédéric Cren.

IVA - The article describes a routine corporate governance process involving a planned CEO transition and shareholder meeting, with no significant positive or negative implications for the company's performance

#General Meeting #CEO transition #compensation policy #shareholders

Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025

GlobeNewswire Inc. • Inventiva

Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025

11/06/2025 04:00 PM • Inventiva disclosed its total number of shares and voting rights as of October 20, 2025, with 145,951,274 shares in circulation and 158,653,570 gross voting rights.

IVA - The article provides standard financial disclosure about share and voting rights without indicating significant positive or negative business developments

#capital #voting rights #shares #biopharmaceutical #MASH

Bimini Capital Management Announces Third Quarter 2025 Results

GlobeNewswire Inc. • Robert E. Cauley

Bimini Capital Management Announces Third Quarter 2025 Results

11/06/2025 04:00 PM • Bimini Capital Management reported net income of $1.8 million for Q3 2025, driven by strong advisory services and investment portfolio performance, with favorable market conditions for mortgage-backed securities investments.

GOOGL - Mentioned as a cloud computing competitor with 13% market share
BMNM - Reported increased net income, expanded advisory service revenues, and benefited from favorable market conditions for mortgage-backed securities

#mortgage-backed securities #financial results #advisory services #investment portfolio

U.S. Global Investors Announces Q1 Fiscal Year 2026 Webcast

GlobeNewswire Inc. • U.S. Global Investors, Inc.

U.S. Global Investors Announces Q1 Fiscal Year 2026 Webcast

11/06/2025 04:00 PM • U.S. Global Investors will host a webcast on November 13 at 7:30 a.m. Central time to discuss fiscal year 2025 financial results, with key executives participating.

GOOG - Mentioned as a cloud computing competitor with 13% market share
GROW - Standard financial reporting announcement with no explicit positive or negative indicators

#webcast #financial results #fiscal year 2025 #investment management

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire Inc. • In8Bio, Inc.

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

11/06/2025 04:00 PM • IN8bio reported financial results and highlighted preclinical data on INB-619, a novel gamma-delta T cell engager, demonstrating potential for deep B cell depletion with minimal adverse effects. The company expanded its INB-100 Phase 1 clinical trial to The Ohio State University and continues advancing its T cell therapy platform.

MSFT - Mentioned as a cloud computing competitor with 20% market share
INAB - Company showed promising preclinical data, expanded clinical trial, reduced expenses, and maintained a strategic focus on developing innovative T cell therapies

#gamma-delta T cell #immunotherapy #preclinical data #clinical trial #B cell depletion

Statement of total voting rights and shares forming the company’s share capital as October 20, 2025

GlobeNewswire Inc. • Inventiva

Statement of total voting rights and shares forming the company’s share capital as October 20, 2025

11/06/2025 04:00 PM • Inventiva, a clinical-stage biopharmaceutical company, reported its total shares outstanding and voting rights as of October 20th, 2025, with 145,951,274 shares and 158,653,570 gross voting rights.

IVA - The article provides a routine financial disclosure about share and voting rights, without indicating significant positive or negative business developments

#shares #voting rights #biopharmaceutical #MASH #clinical trial

Tempus AI: Volatility Equates to Opportunity in AI Leader

Investing.com • Thomas Hughes

Tempus AI: Volatility Equates to Opportunity in AI Leader

11/06/2025 03:34 PM • Tempus AI reported strong Q3 performance with 85% revenue growth, achieving first positive EBITDA quarter and raising year-end guidance. Despite stock price pullback, analysts see potential upside and value in the AI genomics and oncology data services company.

TEM - Strong quarterly performance with 85% revenue growth, first positive EBITDA, raised guidance, and analysts predicting 20% upside potential

#AI #genomics #oncology #data services #earnings #volatility

This AI Stock Just Announced a Stock Split. Is It Time to Buy?

The Motley Fool • Daniel Sparks

This AI Stock Just Announced a Stock Split. Is It Time to Buy?

11/06/2025 03:31 PM • ServiceNow announced a five-for-one stock split, highlighting strong AI-driven product growth with revenue increasing 22% year-over-year and AI product annual contract value expected to double from $0.5B to $1B next year.

OEC - Despite lower reported figures compared to 2024, the company showed strong basic business growth, continued development of key products like Nubeqan, and maintained positive outlook for research and development
NOW - Strong business performance and AI growth potential, but current stock valuation is high and not considered an immediate buy. The stock is recommended for a watchlist rather than immediate purchase.

#AI #stock split #ServiceNow #workflow software #enterprise technology

Centrus Energy Stock Dips On Mixed Q3 Results, Announced Equity Offering Announcement

Benzinga • Evette Mitkov

Centrus Energy Stock Dips On Mixed Q3 Results, Announced Equity Offering Announcement

11/06/2025 03:28 PM • Centrus Energy reported Q3 earnings of 19 cents per share, beating estimates, with sales of $74.9 million. The company announced a potential $1.0 billion equity offering and saw stock price decline despite positive financial performance.

LEU - Mixed financial results with earnings beating estimates but stock price dropping. Positive revenue growth in LEU and Technical Solutions segments, but potential dilution from equity offering created market uncertainty.

#uranium #enrichment #equity offering #Q3 earnings #energy

Should You Buy Micron Stock After Its Monster Run?

The Motley Fool • John Ballard

Should You Buy Micron Stock After Its Monster Run?

11/06/2025 03:22 PM • Micron Technology stock has surged 182% in 2025, driven by high demand for memory chips in AI-optimized data centers. The company's revenue reached a record $37 billion, with earnings jumping 538%, suggesting potential for continued growth in the AI infrastructure market.

MU - Strong financial performance, record revenue, significant earnings growth, and strategic positioning in AI-driven memory chip market

#AI #memory chips #data centers #semiconductor #technology stocks

The Motley Fool • Jeremy Bowman

Why Magnite Stock Was Falling Today

11/06/2025 03:21 PM • Magnite reported strong Q3 earnings with 11% revenue growth and 18% Connected TV revenue increase, but stock fell due to disappointing Q4 growth guidance, particularly in the DV+ business segment.

GOOG - Launched updates to ARCore and Google Lens, expanding AR mapping and object recognition features
MGNI - Despite beating Q3 earnings estimates, the company's weak Q4 growth guidance of 2-5% for its DV+ business caused investor concern and stock price decline

#ad tech #Connected TV #digital advertising #earnings report #stock performance

Follow the Smart Money: 3 Stocks With High Institutional Ownership

Investing.com • Jordan Chussler

Follow the Smart Money: 3 Stocks With High Institutional Ownership

11/06/2025 03:21 PM • The article highlights three stocks with high institutional ownership: Micron Technology, Netflix, and Dutch Bros, which have attracted significant investment from major institutional investors due to strong financial performance and growth potential.

GOOGL - Launched updates to ARCore and Google Lens, expanding AR mapping and object recognition features
MU - 80.84% institutional ownership, 150% stock gain in 2025, strong demand for memory and data center products, partnerships with major tech companies

#institutional ownership #semiconductor #streaming #coffee chain #investment strategy

Warner Bros Discovery Misses Revenue but Studios Strength Offset Weak TV Sales

Investing.com • Dave Kovaleski

Warner Bros Discovery Misses Revenue but Studios Strength Offset Weak TV Sales

11/06/2025 03:17 PM • Warner Bros Discovery reported mixed Q3 results, with strong studio performance offsetting weak TV sales. The company missed revenue estimates but beat earnings expectations, and is considering potential sale or split into two companies in 2026.

META - Mentioned as a key player in AR technology development without specific recent innovations highlighted
WBD - Mixed financial performance with strong studio revenue (up 24%) but declining TV network revenue (down 22%), and potential strategic restructuring

#earnings #media #streaming #studios #revenue #split

Investing in the S&P 500 Is Still a Good Idea, but Here Are 2 Safer Ways to Do It

The Motley Fool • David Jagielski

Investing in the S&P 500 Is Still a Good Idea, but Here Are 2 Safer Ways to Do It

11/06/2025 03:15 PM • The article discusses alternative ways to invest in the S&P 500 index by using ETFs that weight holdings differently, such as revenue-based or equal-weight strategies, to reduce concentration risk in large tech stocks.

MSFT - Listed as a market player but no specific AR developments mentioned in the article
NVDA - Mentioned as one of the top holdings in market-cap weighted ETFs, potentially overvalued

#S&P 500 #ETF #investment strategy #market diversification #risk management

Prediction: The Best-Performing Artificial Intelligence Stock of 2026 Won't Be a Chipmaker

The Motley Fool • Harsh Chauhan

Prediction: The Best-Performing Artificial Intelligence Stock of 2026 Won't Be a Chipmaker

11/06/2025 03:05 PM • Palantir Technologies is predicted to outperform semiconductor stocks in 2026 due to its robust Artificial Intelligence Platform (AIP), impressive revenue growth, and expanding customer base.

PLTR - Reported 63% year-over-year revenue increase, 394% stock rise in past year, growing customer base, record contract values, and strong AI platform adoption

#AI #artificial intelligence #software #stocks #technology #investment

VEON’s Beeline Kazakhstan Partners with Starlink Direct to Cell to Launch Satellite Connectivity to Kazakhstan, with Support from Kazakhstan Ministry of Artificial Intelligence and Digital Development

GlobeNewswire Inc. • Veon Ltd.

VEON’s Beeline Kazakhstan Partners with Starlink Direct to Cell to Launch Satellite Connectivity to Kazakhstan, with Support from Kazakhstan Ministry of Artificial Intelligence and Digital Development

11/06/2025 03:00 PM • Beeline Kazakhstan is partnering with Starlink Direct to Cell to provide satellite connectivity across Kazakhstan, starting with messaging services in 2026 and aiming to expand mobile internet coverage in remote areas.

VEON - First global telecom operator to sign multi-country framework agreement with Starlink, demonstrating technological innovation

#satellite connectivity #mobile internet #Kazakhstan #remote areas #digital infrastructure

Kentucky First Federal Bancorp Releases Earnings

GlobeNewswire Inc. • Don D. Jennings/Tyler Eades

Kentucky First Federal Bancorp Releases Earnings

11/06/2025 02:57 PM • Kentucky First Federal Bancorp reported net income of $344,000 for Q3 2025, a significant improvement from a net loss of $15,000 in the same quarter last year, driven by higher net interest income and reduced interest expenses.

UNH - Minimal premarket movement, expected earnings of $2.81 per share on $113.06 billion revenue
KFFB - Reported substantial quarterly earnings improvement, increased net interest income by 33.9%, decreased interest expenses, and showed strategic financial management with no loan loss provisions

#earnings #banking #financial performance #net income #interest rates

CarMax Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Substantial Losses of Lead Plaintiff Deadline in Class Action Lawsuit Against CarMax, Inc. - KMX

GlobeNewswire Inc. • Kahn Swick & Foti, Llc

CarMax Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Substantial Losses of Lead Plaintiff Deadline in Class Action Lawsuit Against CarMax, Inc. - KMX

11/06/2025 02:55 PM • CarMax faces a securities class action lawsuit alleging failure to disclose material information during June 20-September 24, 2025. The company reported decreased sales and lower earnings, causing a 20.07% stock price drop.

CCJ - Rose 9.67% after announcing transformational nuclear power reactor partnership with U.S. Government
KMX - Stock price fell 20.07% after reporting decreased retail unit sales, comparable store unit sales, wholesale units, and lower net earnings per share, suggesting potential financial and legal challenges

#securities lawsuit #class action #financial disclosure #stock price #investor losses

Super Micro Stock Tests Support as AI Expansion Outpaces Its Cash Engine

Investing.com • Itai Smidt

Super Micro Stock Tests Support as AI Expansion Outpaces Its Cash Engine

11/06/2025 02:53 PM • Super Micro Computer reported Q1 FY2026 revenue of $5.0 billion, missing expectations, but raised full-year guidance to $36 billion driven by AI platform orders. The company faces challenges with margin compression and cash flow management while expanding AI infrastructure capabilities.

DDD - Gained 9.45% after securing strategic investment and winning manufacturing agreements
SMCI - Mixed financial performance with strong AI order backlog but declining margins and negative cash flow

#AI #data center #infrastructure #hyperscale #GPU #margins